<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.onhealthcare.tech/p/a-reasoning-model-reread-376-unsolved</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-22T12:28:18+00:00</news:publication_date><news:title>A Reasoning Model Reread 376 Unsolved Rare Disease Genomes at Boston Children’s &amp; Surfaced 18 New Diagnoses: What the 4.8% Yield Means, and Why the Real Prize Is Reanalysis as Standing Infrastructure</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/part-ii-how-midjourneys-60-second</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-21T13:33:11+00:00</news:publication_date><news:title>Part II: How Midjourney’s 60-second full-body ultrasound scanner became a LinkedIn fever dream &amp; what the Butterfly chip deal, the wellness-lane FDA play &amp; overdiagnosis math tell healthcare investors</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/part-i-how-midjourneys-60-second</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-21T13:31:41+00:00</news:publication_date><news:title>Part I: How Midjourney’s 60-second full-body ultrasound scanner became a LinkedIn fever dream &amp; what the Butterfly chip deal, the wellness-lane FDA play &amp; overdiagnosis math tell healthcare investors</news:title></news:news></url></urlset>